Literature DB >> 2123808

Posttranslational modification of proteins by isoprenoids in mammalian cells.

W A Maltese1.   

Abstract

Isoprenylation is a posttranslational modification that involves the formation of thioether bonds between cysteine and isoprenyl groups derived from pyrophosphate intermediates of the cholesterol biosynthetic pathway. Numerous isoprenylated proteins have been detected in mammalian cells. Those identified include K-, N-, and H-p21ras, ras-related GTP-binding proteins such as G25K (Gp), nuclear lamin B and prelamin A, and the gamma subunits of heterotrimeric G proteins. The modified cysteine is located in the fourth position from the carboxyl terminus in every protein where this has been studied. For p21ras, the last three amino acids are subsequently removed and the exposed cysteine is carboxylmethylated. Similar processing events may occur in lamin B and G protein gamma subunits, but the proteolytic cleavage in prelamin A occurs upstream from the modified cysteine. Lamin B and p21ras are modified by C15 farnesyl groups, whereas other proteins such as the G protein gamma subunits are modified by C20 geranylgeranyl chains. Separate enzymes may catalyze these modifications. The structural features that govern the ability of particular proteins to serve as substrates for isoprenylation by C15 or C20 groups are not completely defined, but studies of the p21ras modification using purified farnesyl:protein transferase suggest that the sequence of the carboxyl-terminal tetrapeptide is important. Isoprenylation plays a critical role in promoting the association of p21ras and the lamins with the cell membrane and nuclear envelope, respectively. Future studies of the role of isoprenylation in the localization and function of ras-related GTP-binding proteins and signal-transducing G proteins should provide valuable new insight into the link between isoprenoid biosynthesis and cell growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123808     DOI: 10.1096/fasebj.4.15.2123808

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  88 in total

1.  Structural analysis of protein prenyl groups and associated C-terminal modifications.

Authors:  M E Whitten; K Yokoyama; D Schieltz; F Ghomashchi; D Lam; J R Yates; K Palczewski; M H Gelb
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

3.  Production, processing and partial purification of functional G protein beta gamma subunits in baculovirus-infected insect cells.

Authors:  J D Robishaw; V K Kalman; K L Proulx
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

Review 4.  Signal transduction enzymes of vertebrate photoreceptors.

Authors:  J B Hurley
Journal:  J Bioenerg Biomembr       Date:  1992-04       Impact factor: 2.945

Review 5.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 6.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

7.  A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity.

Authors:  K Yokoyama; G W Goodwin; F Ghomashchi; J A Glomset; M H Gelb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

8.  Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.

Authors:  Wenwen Zhang; Xiaoxiao Yang; Yuanli Chen; Wenquan Hu; Lipei Liu; Xiaomeng Zhang; Mengyang Liu; Lei Sun; Ying Liu; Miao Yu; Xiaoju Li; Luyuan Li; Yan Zhu; Qing Robert Miao; Jihong Han; Yajun Duan
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-12-05       Impact factor: 4.698

9.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Inhibition of growth of cultured tobacco cells at low concentrations of lovastatin is reversed by cytokinin.

Authors:  D N Crowell; M S Salaz
Journal:  Plant Physiol       Date:  1992-12       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.